Annual Operating Margin
-430.15%
-268.12%-165.48%
December 31, 2023
Summary
- As of February 7, 2025, ABUS annual operating profit margin is -430.15%, with the most recent change of -268.12% (-165.48%) on December 31, 2023.
- During the last 3 years, ABUS annual operating margin has risen by +398.15% (+48.07%).
- ABUS annual operating margin is now -1399.15% below its all-time high of 33.11%, reached on December 31, 2006.
Performance
ABUS Operating Margin Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Margin
-1304.78%
-66.54%-5.37%
September 30, 2024
Summary
- As of February 7, 2025, ABUS quarterly operating profit margin is -1304.78%, with the most recent change of -66.54% (-5.37%) on September 30, 2024.
- Over the past year, ABUS quarterly operating margin has dropped by -52.63% (-4.20%).
- ABUS quarterly operating margin is now -2448.42% below its all-time high of 55.56%, reached on December 31, 2010.
Performance
ABUS Quarterly Operating Margin Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Margin Formula
Operating Profit Margin = Operating Profit
Revenue ✕ 100%
Revenue ✕ 100%
ABUS Operating Margin Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -165.5% | -4.2% |
| 3 y3 years | +48.1% | -288.9% |
| 5 y5 years | +63.6% | -288.9% |
ABUS Operating Margin Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -165.5% | +34.0% | -1423.7% | at low |
| 5 y | 5-year | -165.5% | +63.8% | -1423.7% | at low |
| alltime | all time | -1399.2% | +98.1% | -2448.4% | +89.6% |
Arbutus Biopharma Operating Margin History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -1304.78%(+5.4%) |
| Jun 2024 | - | -1238.24%(-1.1%) |
| Mar 2024 | - | -1252.15%(+30.9%) |
| Dec 2023 | -430.15%(+165.5%) | -956.64%(+108.7%) |
| Sep 2023 | - | -458.42%(+12.1%) |
| Jun 2023 | - | -408.97%(+59.6%) |
| Mar 2023 | - | -256.32%(-23.6%) |
| Dec 2022 | -162.03%(-75.2%) | -335.52%(+13.5%) |
| Sep 2022 | - | -295.63%(+202.9%) |
| Jun 2022 | - | -97.61%(+14.0%) |
| Mar 2022 | - | -85.63%(-86.7%) |
| Dec 2021 | -652.08%(-21.3%) | -642.64%(+22.3%) |
| Sep 2021 | - | -525.51%(-31.8%) |
| Jun 2021 | - | -770.63%(+4.7%) |
| Mar 2021 | - | -735.78%(+8.5%) |
| Dec 2020 | -828.30%(-30.2%) | -677.95%(-31.6%) |
| Sep 2020 | - | -991.27%(+15.3%) |
| Jun 2020 | - | -859.84%(-1.2%) |
| Mar 2020 | - | -870.42%(+6.8%) |
| Dec 2019 | -1186.91%(+0.6%) | -814.83%(+35.4%) |
| Sep 2019 | - | -601.96%(-81.1%) |
| Jun 2019 | - | -3182.39%(+14.0%) |
| Mar 2019 | - | -2791.46%(+196.2%) |
| Dec 2018 | -1180.35%(+80.1%) | -942.55%(-17.4%) |
| Sep 2018 | - | -1140.96%(-27.1%) |
| Jun 2018 | - | -1564.71%(+33.9%) |
| Mar 2018 | - | -1168.80%(+52.3%) |
| Dec 2017 | -655.44%(-90.3%) | -767.60%(+310.2%) |
| Sep 2017 | - | -187.13%(-90.0%) |
| Jun 2017 | - | -1875.36%(-75.9%) |
| Mar 2017 | - | -7786.81%(+217.6%) |
| Dec 2016 | -6726.49%(+2733.5%) | - |
| Sep 2016 | - | -2451.55%(-80.5%) |
| Jun 2016 | - | -12.60 K%(+280.2%) |
| Mar 2016 | - | -3312.94%(+2877.7%) |
| Dec 2015 | -237.39%(+7.7%) | -111.26%(-77.6%) |
| Sep 2015 | - | -495.65%(+21.3%) |
| Jun 2015 | - | -408.69%(+119.7%) |
| Mar 2015 | - | -186.05%(-24.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2014 | -220.50%(+180.6%) | -247.06%(+57.5%) |
| Sep 2014 | - | -156.90%(-69.8%) |
| Jun 2014 | - | -520.32%(+286.9%) |
| Mar 2014 | - | -134.49%(+315.6%) |
| Dec 2013 | -78.58%(+23.5%) | -32.36%(-73.7%) |
| Sep 2013 | - | -123.22%(+14.1%) |
| Jun 2013 | - | -107.98%(-23.1%) |
| Mar 2013 | - | -140.43%(+141.4%) |
| Sep 2012 | - | -58.18%(-18.4%) |
| Jun 2012 | - | -71.34%(-3.5%) |
| Mar 2012 | - | -73.93%(+23.4%) |
| Dec 2011 | -63.61%(+105.9%) | -59.89%(+48.1%) |
| Sep 2011 | - | -40.43%(-50.8%) |
| Jun 2011 | - | -82.20%(+16.1%) |
| Mar 2011 | - | -70.83%(-227.5%) |
| Dec 2010 | -30.90%(-47.4%) | 55.56%(-331.9%) |
| Sep 2010 | - | -23.96%(-85.8%) |
| Jun 2010 | - | -168.93%(-1.4%) |
| Mar 2010 | - | -171.28%(+403.9%) |
| Dec 2009 | -58.75%(-32.1%) | -33.99%(-57.0%) |
| Sep 2009 | - | -79.00%(+33.8%) |
| Jun 2009 | - | -59.03%(-22.9%) |
| Mar 2009 | - | -76.56%(-2220.8%) |
| Dec 2008 | -86.54%(-622.3%) | 3.61%(-105.4%) |
| Sep 2008 | - | -66.55%(-67.8%) |
| Jun 2008 | - | -206.77%(+355.4%) |
| Mar 2008 | - | -45.40%(-2370.0%) |
| Dec 2007 | 16.57%(-50.0%) | 2.00%(-93.0%) |
| Sep 2007 | - | 28.69%(+342.1%) |
| Jun 2007 | - | 6.49% |
| Dec 2006 | 33.11%(-504.8%) | - |
| Dec 2005 | -8.18%(-95.7%) | - |
| Dec 2004 | -192.13%(-84.8%) | - |
| Dec 2003 | -1268.10%(+169.1%) | - |
| Dec 2002 | -471.25%(-11.0%) | - |
| Dec 2001 | -529.66%(-97.6%) | - |
| Dec 2000 | -22.24 K%(+3003.6%) | - |
| Dec 1999 | -716.68%(+0.5%) | - |
| Dec 1998 | -713.22% | - |
FAQ
- What is Arbutus Biopharma annual operating profit margin?
- What is the all time high annual operating margin for Arbutus Biopharma?
- What is Arbutus Biopharma annual operating margin year-on-year change?
- What is Arbutus Biopharma quarterly operating profit margin?
- What is the all time high quarterly operating margin for Arbutus Biopharma?
- What is Arbutus Biopharma quarterly operating margin year-on-year change?
What is Arbutus Biopharma annual operating profit margin?
The current annual operating margin of ABUS is -430.15%
What is the all time high annual operating margin for Arbutus Biopharma?
Arbutus Biopharma all-time high annual operating profit margin is 33.11%
What is Arbutus Biopharma annual operating margin year-on-year change?
Over the past year, ABUS annual operating profit margin has changed by -268.12% (-165.48%)
What is Arbutus Biopharma quarterly operating profit margin?
The current quarterly operating margin of ABUS is -1304.78%
What is the all time high quarterly operating margin for Arbutus Biopharma?
Arbutus Biopharma all-time high quarterly operating profit margin is 55.56%
What is Arbutus Biopharma quarterly operating margin year-on-year change?
Over the past year, ABUS quarterly operating profit margin has changed by -52.63% (-4.20%)